Clinical Trials Browser

Interventional × Has results × rovalpituzumab tesirine × Clear all

NCT02674568 2021-07-30

TRINITY

Phase 2 Completed

342 enrolled 18 charts

Recurrence, Small Cell Lung Carcinoma

NCT03033511 2021-07-29

MERU

Phase 3 Terminated

748 enrolled 13 charts

Neoplasms, Small Cell Lung Carcinoma

NCT03061812 2021-02-23

TAHOE

Phase 3 Completed

444 enrolled 16 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT03543358 2021-01-05

A Long-Term Study of Rovalpituzumab Tesirine

Phase 2 Completed

3 enrolled 6 charts

Neoplasms

NCT02709889 2020-10-19

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Phase 1/2 Terminated

200 enrolled 21 charts

CNSDermatologic

Glioblastoma, Melanoma, Carcinoma, Medullary

NCT03026166 2020-07-17

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Terminated

42 enrolled 15 charts

Neoplasms, Small Cell Lung Carcinoma

NCT01901653 2018-08-09

Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

Phase 1/2 Completed

82 enrolled 28 charts

Small Cell Lung Carcinoma